Previous Page  26 / 33 Next Page
Information
Show Menu
Previous Page 26 / 33 Next Page
Page Background

Volume 4

Journal of Infectious Diseases and Treatment

ISSN: 2472-1093

Page 62

Euro Infectious Diseases 2018 &

Histopathology 2018

September 27-29, 2018

&

JOINT EVENT

September 27-29, 2018 Rome, Italy

5

th

International Conference on

Histopathology & Cytopathology

10

th

Euro-Global Conference on

Infectious Diseases

Risk factors of multi drug resistant tuberculosis among pediatric patients: Aretrospective cohort study

Raziel Vina S Espino

East Avenue Medical Center, Philippines

T

his study determines the risk factors of pediatric patients diagnosed with multi drug resistant tuberculosis (MDR-TB)

conducted in a tertiary hospital in Quezon City and Health Centers from January 2011 to December 2016. A minimum

cohort study of 156 patients of 0-18 years old, either bacteriologically confirmed or clinically diagnosed tuberculosis was

included in the study. Patients whose significant data of their charts went missing were excluded in the analysis. The following

information were gathered a) demographic profile of age, gender, nutritional status, socioeconomic status, district b) clinical

profile: history of exposure, results of laboratories, clinical presentation, delay in treatment, previous treatment with tuberculosis

and outcome. 162 patients were analyzed, 12/162 had MDR- TB and 150/162 had Non MDR-TB. Results of univariate analysis

showed that age and symptoms of weight loss, back pain, night sweats and fever had significant association with MDR-TB, of

these factors, back pain (p=0.001; RR:31.771; 95% CI:3.801, 265.554) and fever (p=0.020; RR:7.6587; 95% CI:1.380, 42.494)

were independent factors significantly related with MDR-TB. Age, weight loss, back pain, night sweats and fever had significant

association with MDR-TB. Larger sample population and a prospective study is recommended to assess the epidemiologic data

and further identify other possible risk factors for resistance.

razielespino@gmail.com

J Infec Dis Treat 2018, Volume 4

DOI: 10.21767/2472-1093-C1-003